SureTrader SureTrader
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, integral, Stock Barber, BADALI, baryoboy
Search This Board:
Last Post: 10/22/2016 10:57:22 AM - Followers: 472 - Board type: Free - Posts Today: 3


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.

One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

Material Disclosure to Shareholdrs EPGL MED JOINT PATENT VALIDATION
(Includes EPGL MED, COOPERVISION, David T.Markus, Aurthur Back, Luke A.Kilyk, Michael Hayes)

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)

Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.

Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space

EPGL and AT&T Sign Development Agreement

About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares.  Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report  Q3, 2015
** Press Release **  - Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015

** OTC Disclosure ** - Supplemental Information- Retirement of Common Shares by Beneficial Shareholders Commences

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restructure in 2012***
Total number of shareholders of record 700 approximate 

The Company leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**

Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)

Follow EPGL on Twitter @epglMED
Follow EPGL on the WEB at



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#110429  Sticky Note Agree shareholders have something great. franck92 10/08/16 01:34:47 PM
#108787  Sticky Note EPGL Wins Allowance on First Patent vikingzskillz 08/30/16 10:08:17 PM
#95482  Sticky Note Press releases or other company communication should not Brian !!Retired!! 01/12/16 12:14:18 PM
#110810   Quote: Bottom line is this, it's on the stinkypinky...Having kura 10/22/16 10:57:22 AM
#110809   It's obvious that people are trying to scare rostam92 10/22/16 02:17:59 AM
#110808   Could you explain your opinion to enlighten us ? franck92 10/22/16 12:03:06 AM
#110807   275k sold vs 775k bought? Lol wow...clearly manipulation...extreme rostam92 10/21/16 11:57:07 PM
#110806   3 pennies. Big news with patents. The sky skorz 10/21/16 10:04:50 PM
#110805   The disconnection is being in pink sheets. Some kura 10/21/16 07:26:07 PM
#110804   Its a start up company. Patent news H8ster 10/21/16 06:45:46 PM
#110803   The more patent the worse this stock performs....there WhymeMA 10/21/16 06:34:47 PM
#110802   Sounds good. Hank Kerchief 10/21/16 03:12:14 PM
#110801   No reason for them to do that. H8ster 10/21/16 02:48:23 PM
#110799   "033 (by end of day)" Only a paint AJCash 10/21/16 02:28:00 PM
#110798   Manipulation at it's absolute finest! Fun to H8ster 10/21/16 02:10:21 PM
#110797   I you guys feel. Im IloveTransformers1984 10/21/16 02:01:27 PM
#110796   Why not? It would make shareholders happy. Hank Kerchief 10/21/16 02:00:05 PM
#110795   This will never happen. No reason for Hayes YogInvest 10/21/16 01:57:58 PM
#110794   That would work! We need enough volume gr8f1 10/21/16 01:55:24 PM
#110793   Maybe now is the time to get serious Hank Kerchief 10/21/16 01:54:03 PM
#110792   Another patent or two coupled with a PR gr8f1 10/21/16 01:54:02 PM
#110791   So we get patent approvals and still we shakamac 10/21/16 01:48:51 PM
#110790   775 000 buys 275 000 sold franck92 10/21/16 01:14:56 PM
#110789   I understand you, same feeling, not judging you. franck92 10/21/16 01:04:01 PM
#110788   Hahahaha! Those levels would indeed be a H8ster 10/21/16 12:53:35 PM
#110787   Haha ...$43 trade just to undercut ask. I Doubledown22 10/21/16 12:21:35 PM
#110786   Im really intrigued by the new patent. IloveTransformers1984 10/21/16 12:19:44 PM
#110784   This POS has nothing ,no productions and no IloveTransformers1984 10/21/16 12:09:33 PM
#110782   Not carrots, only expression of a business which franck92 10/21/16 11:42:19 AM
#110781   Did you see the last "elastic circuit" patent ? franck92 10/21/16 11:40:02 AM
#110780   yep - the carrot dangling never stops. Atlanta1 10/21/16 11:39:11 AM
#110779   Tweet "EPGL traders will do their thing. franck92 10/21/16 11:37:12 AM
#110778   Ulcers ? with 2 patents ? No sorry franck92 10/21/16 11:35:53 AM
#110777   Investors are starting to understand that patents alone Stock Barber 10/21/16 11:34:39 AM
#110776   The patents are really moving EPGL stock up flaflyersfan 10/21/16 11:30:25 AM
#110775 this point anyways...i might put ip the IloveTransformers1984 10/21/16 11:28:29 AM
#110774   Blood will flow in the streets on this Doubledown22 10/21/16 11:14:01 AM
#110771   Who is Obama ??? what is the franck92 10/21/16 09:37:57 AM
#110770   I don't see Obama taking notice of EPGL. AJCash 10/21/16 09:32:10 AM
#110769   I was responding to a poster who said kura 10/20/16 07:21:12 PM
#110768   Yep, the next great application is "PIEZOELECTRIC ENERGY franck92 10/20/16 06:53:29 PM
#110767   I disagree... I believe with just a few gr8f1 10/20/16 06:27:39 PM
#110766   This will continue until Epgl moves out of kura 10/20/16 06:19:43 PM
#110765   And the pps iiisss? Still the same actually Sone 10/20/16 05:48:09 PM
#110764   Haha. This is worthless. No real Valiant 10/20/16 05:02:43 PM
#110763   But other than all those drawbacks it will Doubledown22 10/20/16 04:38:43 PM
#110762   Interesting. Nice device. Tested on 30 Hank Kerchief 10/20/16 04:17:07 PM
#110761   No there will still be plenty of bid Doubledown22 10/20/16 03:56:41 PM
#110759   It cracks me up they see this trade gr8f1 10/20/16 03:43:17 PM
#110757   Epgl second-patent-allowance-carrot tastes good, lol. No 2 so kura 10/20/16 03:35:34 PM
#110756   Can't wait for all the shareholders that have gr8f1 10/20/16 03:26:18 PM
#110755   Absolutely fantastic news today! As word gets gr8f1 10/20/16 03:22:23 PM
#110754   Congrats to everybody that sold in the low H8ster 10/20/16 03:10:41 PM